All News about Travere Therapeutics IncVia Benzinga
Via GlobeNewswire
Via GlobeNewswire
Earnings Preview For Travere Therapeutics
February 14, 2024
Via Benzinga
Via Benzinga
Via GlobeNewswire
Where Travere Therapeutics Stands With Analysts
December 15, 2023
Via Benzinga
Travere Therapeutics to Present at Upcoming Investor Conferences
February 26, 2024
Via GlobeNewswire
Via GlobeNewswire
Travere Therapeutics Provides Corporate Update and 2024 Outlook
January 08, 2024
Via GlobeNewswire
Calliditas Therapeutics Scores Complete FDA Approval, Broader Label For Lead Kidney Disease Drug
December 21, 2023
Via Benzinga
Exposures
Product Safety
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|